Breast Augmentation — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Breast augmentation (augmentation mammoplasty) is a cosmetic surgical procedure that increases breast volume, improves breast shape, and corrects asymmetry using implants or autologous fat transfer. Implants are either cohesive silicone gel (most common) or saline-filled. Fat transfer augmentation harvests the patient's own adipose tissue via liposuction and injects it into the breast, providing natural results with limited volume increase (typically one cup size). Breast augmentation is the most commonly performed cosmetic surgical procedure globally, with over 4 million procedures performed annually worldwide. The surgery is performed by board-certified plastic surgeons in accredited facilities under general anaesthesia as a day case or with one night's stay. It is indicated for cosmetic enhancement, correction of breast asymmetry, restoration of breast volume following pregnancy or weight loss (involutional changes), and reconstruction after mastectomy when combined with other reconstructive techniques. Breast augmentation (augmentation mammoplasty) is a cosmetic surgical procedure that increases breast volume, improves breast shape, and corrects asymmetry using implants or autologous fat transfer. It is the most commonly performed cosmetic surgical procedure worldwide — over 1.8 million augmentation procedures are reported annually by the International Society of Aesthetic Plastic Surgery (ISAPS). The procedure is performed by board-certified plastic surgeons. Implant-based augmentation uses silicone gel-filled or saline-filled implants available in round or anatomical (teardrop) shapes. Fat transfer augmentation (composite or natural augmentation) harvests fat by liposuction from the abdomen or thighs and injects it into the breast. The choice of technique, implant type, size, and surgical approach is individualised after detailed consultation, anthropometric measurements, and discussion of the patient's aesthetic goals and lifestyle. Regulatory approval and safety standards for implants vary by country.

Ideal candidates are healthy women aged 18 years or older (21 years or older for silicone implants in some regulatory jurisdictions, including the USA) who desire breast enhancement, asymmetry correction, or volume restoration following pregnancy-related changes. Good candidates have realistic expectations, adequate breast tissue coverage for implant placement, and stable weight (ideally within 6 months of target weight). Smokers are advised to cease smoking at least 6 weeks pre-operatively to reduce wound healing complications. Contraindications include active breast infection or mastitis, undiagnosed breast mass requiring investigation, pregnancy, breastfeeding (delay 3–6 months after cessation), uncontrolled autoimmune disease, and severe psychological co-morbidity. Preoperative mammography or breast ultrasound is performed in women over 35 or with a family history of breast cancer. Women with BRCA1 or BRCA2 mutations seeking augmentation should receive specific oncological counselling regarding MRI surveillance requirements. Bilateral implants are most common; unilateral augmentation corrects significant asymmetry.

Under general anaesthesia, the surgeon marks the inframammary fold, breast footprint, and implant pocket before the patient is positioned supine. The most common incision approach is inframammary (hidden in the breast fold), providing optimal visibility and control; periareolar (around the areola) and transaxillary (through the armpit) approaches are alternatives with their own trade-offs. The implant pocket is dissected either subglandular (between breast tissue and pectoralis muscle — shorter recovery, higher capsular contracture risk), subfascial, or submuscular/dual-plane (beneath the pectoralis major — preferred for thin patients with minimal native tissue). The chosen implant — selected pre-operatively in consultation by profile, base width, projection, and volume — is placed and the pocket irrigated with antibiotic solution (triple antibiotic solution or betadine to reduce bacterial contamination and capsular contracture). Implants are available in round and anatomical (teardrop) shapes; textured and smooth surfaces. Layered closure is performed with absorbable sutures. Total operative time is 1–2 hours. Drains are rarely necessary. Under general anaesthesia, the surgeon marks the inframammary fold, breast footprint, and implant pocket before positioning the patient supine. The inframammary incision (most common) provides wide access with a well-concealed scar. Periareolar and transaxillary approaches are alternatives. A pocket is created either subglandular (between the gland and pectoralis fascia), submuscular (under the pectoralis major muscle — reduces palpability and risk of capsular contracture), or dual-plane (partially beneath pectoralis). The selected implant is inserted, positioned, and checked for symmetry with the patient temporarily elevated to sitting position. Drains may be placed in submuscular pockets. The wound is closed in multiple layers and Steri-Strips applied. Fat transfer augmentation uses a blunt-tipped cannula to inject purified autologous fat in multiple small-volume passes throughout the breast parenchyma to maximise graft take. Procedure duration is 60–90 minutes for implant-based augmentation.

Patient satisfaction following breast augmentation consistently exceeds 90% across multiple international studies, with significant improvements in body image, self-confidence, and quality of life reported by the majority of recipients. Cohesive silicone gel implants produce natural breast feel and appearance superior to saline implants, with lower rupture rates (1–2% over 10 years) and minimal visible rippling even in thin patients. Volume and shape improvements are immediate and lasting — implants typically remain satisfactory for 10–20 years without replacement in the absence of complications. Fat transfer augmentation is an alternative offering natural feel, no foreign body, and simultaneous body contouring at the donor site. From a medical tourism perspective, breast augmentation in India costs approximately INR 1,00,000–2,50,000 (USD 1,200–3,000), compared to USD 8,000–15,000 in the USA or GBP 6,000–12,000 in the UK, at JCI-accredited plastic surgery centres. Restoration of breast volume after pregnancy (post-partum involution) dramatically improves satisfaction with physical appearance for many women.

Capsular contracture — hardening of the scar tissue capsule that forms around every implant — is the most common long-term complication, occurring in approximately 10–20% of patients within 10 years; risk is lowest with submuscular placement and smooth surface implants. Implant rupture occurs in approximately 1–4% of silicone implants within 10 years; silent silicone rupture (detectable only on MRI) requires routine MRI surveillance every 3 years from year 3 post-implantation per FDA guidance. Infection (1–2%) may require antibiotic treatment or, rarely, implant removal. Sensation changes (hypoesthesia or hypersensitivity of nipple and areola) affect up to 15% of patients, usually improving over 12 months. Textured implants carry an extremely low (approximately 1 in 30,000) risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare but treatable cancer of the capsule. Implant malposition, asymmetry, rippling, and dissatisfaction with size may require revision surgery (reported in 10–15% within 10 years). Implants are not lifetime devices; replacement may be required over time.

Patients are discharged the same day or after one night following breast augmentation. A surgical bra providing firm support is worn continuously for 6 weeks. Significant bruising and swelling are normal for the first 2–4 weeks; the final implant position and shape settle over 3–6 months as swelling resolves and implants descend into their final position. Pain is managed with regular paracetamol and ibuprofen; stronger analgesics are prescribed for the first 24–48 hours. Upper body activity and strenuous exercise are avoided for 4–6 weeks to allow secure pocket healing and prevent implant migration. Light walking is encouraged from day 1. Return to desk work is typically at 1–2 weeks; physical labour at 4–6 weeks. Driving is delayed until full upper body movement is pain-free, usually 10–14 days. Showering is permitted at 48 hours; swimming and baths after 4–6 weeks. Follow-up appointments are scheduled at 1–2 weeks, 6 weeks, and 12 months. Implant surveillance by MRI every 3 years from year 3 is recommended for silicone implants.